Jared Josleyn

Head of General Medicines Digital Health Care
Sanofi

​​​​
​Jared Josleyn joined Sanofi in March of 2022 and is Sanofi’s Global Head of Digital Healthcare. In his role at Sanofi, Jared is responsible developing a compelling and novel vision and strategy for Sanofi’s digital healthcare business starting in the cardiometabolic space, creating and driving this new business across different geographies around the world. In addition to this, Jared is also responsible for Sanofi’s ongoing key initiatives such as Connected Ecosystems (connected pens, apps, platform, monitoring devices) for the management of insulin patients.
 
Prior to Sanofi, Jared served as the internal Founder of Walgreens Health within Walgreens Boots Alliance and Chief Product and Experience, where he created, developed, and launched Walgreen’s Health. Before joining WBA, Jared was at Alphabet where he was the Head of Consumer Healthcare Strategy and Corporate Development for Google Health and the Global Head of Corporate Development for Verily.  At Alphabet, Jared was responsible for strategic development, new business formation and development, M&A, and strategic alliances in healthcare.  Jared also spent a number of years in the pharmaceutical industry with Eli Lilly and Company and Elanco Animal Health creating new strategies and go-to-market models and developing new businesses in the private equity markets with E&A Companies, LLC. 
 
Jared earned his J.D. from Indiana University Summa Cum Laude, his MBA with Distinction from Indiana University’s Kelley School of Business, and a Bachelor of Science with Distinction in Economics from Purdue University’s Krannert School of Business. 

Speech title & Synopsis

Building a Digital Health Ecosystem

Patient-centricity fails to enable preventative and personalized health and reduces the whole-person to a mere condition. This leads to high cost, suboptimal access, variable quality, and health inequity.
 
Overtime, we have made healthcare more exclusive instead of more inclusive. Today, the long expected third revolution of pharma can happen. We can radically improve healthcare delivery for all and for good.
 
We can drastically shift the paradigm and transform the practice of medicine by enabling an open, person-centered, tech enabled health ecosystem. A decentralized community of care, putting the power of care in the hands of people.
 
Our mission is to create a new healthcare ecosystem that eliminates care walls and places people and their loved ones at the center of care in control of their health and their data empowering them to participate in value creation.
 
In diabetes alone, despite treatment advances, there is still a huge need for improvement to meet people and their loved ones where they are and care for the whole person: People generally want to be treated as their authentic selves, not as an “aggregate diabetic”. They want a system that works for them.
 
We can significantly improve medication adherence, by focusing on behaviors to drive genuine engagement, and by challenging the bias of healthcare induced by lack of consideration for the social determinants of health.
 
With an aging population, a greater prevalence of chronic diseases, and exponential advances in medical and digital technologies, healthcare expenditures globally are expected to eclipse $11 trillion in 2023, representing a significant share of GDP. We can partner with healthcare authorities to collectively become more resilient whilst contributing to containing costs.
 
All data outside of healthcare are 85% predictive to outcomes. We can deliver a tech architecture with a patient first data design, driving innovation whilst preserving data privacy.